{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:05:47Z","timestamp":1789502747192,"version":"build-2803163510"},"reference-count":86,"publisher":"King Faisal Specialist Hospital and Research Centre","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Saudi Medicine"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.5144\/0256-4947.2015.1","type":"journal-article","created":{"date-parts":[[2017,3,25]],"date-time":"2017-03-25T10:30:38Z","timestamp":1490437838000},"page":"1-12","source":"Crossref","is-referenced-by-count":56,"title":["2015 Guidelines for Osteoporosis in Saudi Arabia: Recommendations from the Saudi Osteoporosis Society"],"prefix":"10.5144","volume":"35","author":[{"given":"Yousef","family":"Al-Saleh","sequence":"first","affiliation":[{"name":"College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad","family":"Sulimani","sequence":"additional","affiliation":[{"name":"College of Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Sabico","sequence":"additional","affiliation":[{"name":"Biomarkers Research Program and Prince Mutaib Chair for Biomarkers of Osteoporosis, Biochemistry Department, College of Science, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"Raef","sequence":"additional","affiliation":[{"name":"Department of Medicine, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Fouda","sequence":"additional","affiliation":[{"name":"College of Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Alshahrani","sequence":"additional","affiliation":[{"name":"College of Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Al Shaker","sequence":"additional","affiliation":[{"name":"Department of Surgery, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma","family":"Al Wahabi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Prince Sultan Military Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mir","family":"Sadat-Ali","sequence":"additional","affiliation":[{"name":"College of Medicine, Dammam University, Dammam, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Al Rayes","sequence":"additional","affiliation":[{"name":"Department of Medicine, Prince Sultan Military Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salwa","family":"Al Aidarous","sequence":"additional","affiliation":[{"name":"College of Medicine, King Abdulaziz Medical City, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siham","family":"Saleh","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Prince Sultan Cardiac Center, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fakhr","family":"Al Ayoubi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, King Fahad Cardiac Center, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser M.","family":"Al-Daghri","sequence":"additional","affiliation":[{"name":"Biomarkers Research Program and Prince Mutaib Chair for Biomarkers of Osteoporosis, Biochemistry Department, College of Science, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3134","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis and therapy","volume":"285","author":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy","year":"2001","journal-title":"JAMA"},{"issue":"10","key":"e_1_3_3_3_2","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician\u2019s guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman F","year":"2014","journal-title":"Osteoporos Int"},{"key":"e_1_3_3_4_2","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.2106\/JBJS.L.01781","article-title":"Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009","volume":"96","author":"Balasubramanian A","year":"2014","journal-title":"J Bone Joint Surg Am"},{"key":"e_1_3_3_5_2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrendo.2014.51","article-title":"Geographic and ethnic disparities in osteoporotic fractures","volume":"10","author":"Cauley JA","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"e_1_3_3_6_2","unstructured":"Glucocorticoid-induced osteoporosis: guidelines for prevention and treatment . London: Royal College of Physicians; 2002. https:\/\/www.nos.org.uk\/netcommunity\/document.doc?id=423."},{"key":"e_1_3_3_7_2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s11657-014-0182-3","article-title":"Estimating prevalence of osteoporosis: examples from industrialized countries","volume":"9","author":"Wade SW","year":"2014","journal-title":"Arch Osteoporos"},{"key":"e_1_3_3_8_2","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrendo.2014.125","article-title":"Fracture mortality: associations with epidemiology and osteoporosis treatment","volume":"10","author":"Sattui SE","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"e_1_3_3_9_2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 2005\u20132025","volume":"22","author":"Burge R","year":"2007","journal-title":"J Bone Miner Res"},{"key":"e_1_3_3_10_2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11657-013-0137-0","article-title":"Osteoporosis in the European Union: a compendium of country-specific reports","volume":"8","author":"Svedboum A","year":"2013","journal-title":"Arch Osteoporos"},{"issue":"6","key":"e_1_3_3_11_2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00223-007-9090-5","article-title":"Economic implications of osteoporosis-related femoral fractures in Saudi Arabian society","volume":"81","author":"Bubshait D","year":"2007","journal-title":"Calcif Tissue Int"},{"key":"e_1_3_3_12_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s002239900652","article-title":"Bone mineral density of spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy and lactation","volume":"65","author":"Ghannam NN","year":"1999","journal-title":"Calcif Tissue Int"},{"key":"e_1_3_3_13_2","first-page":"953","article-title":"Osteoporosis in postmenopausal Saudi women using dual x-ray bone densitometry","volume":"24","author":"El-Desouki MI","year":"2003","journal-title":"Saudi Med J"},{"issue":"11","key":"e_1_3_3_14_2","first-page":"1623","article-title":"Bone mineral density among postmenopausal Saudi women","volume":"25","author":"Sadat-Ali M","year":"2004","journal-title":"Saudi Med J"},{"key":"e_1_3_3_15_2","first-page":"30","article-title":"Bone mineral density of the spine and femur in the normal Saudi population","volume":"16","author":"El-Desouki M","year":"1995","journal-title":"Saudi Med J"},{"key":"e_1_3_3_16_2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2265.2011.04219.x","article-title":"Increased vitamin D supplementation recommended during summer season in the gulf region: a counterintuitive seasonal effect in vitamin D levels in adult, overweight and obese Middle Eastern residents","volume":"76","author":"Al-Daghri NM","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"e_1_3_3_17_2","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00431-012-1686-8","article-title":"Vitamin D deficiency and calcium intake in reference to increased body mass index in children and adolescents","volume":"171","author":"Al-Musharaf S","year":"2012","journal-title":"Eur J Pediatr"},{"issue":"12","key":"e_1_3_3_18_2","first-page":"1765","article-title":"25-Hydroxyvitamin D levels among healthy Saudi Arabian Women","volume":"29","author":"Al-Turki HA","year":"2008","journal-title":"Saudi Med J"},{"key":"e_1_3_3_19_2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00198-004-1639-9","article-title":"Bone mineral density of the spine and femur in healthy Saudis","volume":"16","author":"Ardawi MS","year":"2005","journal-title":"Osteoporos Int"},{"issue":"5","key":"e_1_3_3_20_2","first-page":"774","article-title":"High Prevalence of Osteoporosis In Saudi Men","volume":"28","author":"El-Desouki MI","year":"2007","journal-title":"Saudi Med J"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2006.450"},{"key":"e_1_3_3_22_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S2213-8587(13)70045-7","article-title":"Glucocorticoid- induced osteoporosis: mechanisms, management and future perspectives","volume":"1","author":"Seibel MJ","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"e_1_3_3_23_2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.maturitas.2014.07.005","article-title":"The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)","volume":"79","author":"Rozzoli R","year":"2014","journal-title":"Maturitas"},{"key":"e_1_3_3_24_2","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/ageing\/afu093","article-title":"National osteoporosis society vitamin D guideline summary","volume":"43","author":"Aspray TJ","year":"2014","journal-title":"Age Ageing"},{"key":"e_1_3_3_25_2","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","article-title":"Teriparatide or alendronate in glucocorticoid-induced osteoporosis","volume":"357","author":"Saag K","year":"2007","journal-title":"New Engl J Med"},{"key":"e_1_3_3_26_2","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00198-003-1497-x","article-title":"Which bone densitometry and which skeletal site are clinically useful for monitoring bone mass?","volume":"14","author":"Ito M","year":"2003","journal-title":"Osteoporos Int"},{"key":"e_1_3_3_27_2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4329\/wjr.v5.i11.398","article-title":"Screening and early diagnosis of osteoporosis through X-ray and ultrasound based techniques","volume":"5","author":"Pisani P","year":"2013","journal-title":"World J Radiol"},{"key":"e_1_3_3_28_2","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s001980070027","article-title":"Comparison of six calcaneal quantitative ultrasound devices: precision and hip fractures","volume":"11","author":"Najeh CF","year":"2000","journal-title":"Osteoporos Int"},{"key":"e_1_3_3_29_2","doi-asserted-by":"crossref","first-page":"S407","DOI":"10.1007\/s00198-010-1253-y","article-title":"Development and use of FRAX in osteoporosis","volume":"21","author":"Kanis JA","year":"2010","journal-title":"Osteoporos Int"},{"key":"e_1_3_3_30_2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11914-009-0013-4","article-title":"From relative risk to absolute fracture risk calculation: the FRAX algorithm","volume":"7","author":"McCloskey EV","year":"2009","journal-title":"Curr Osteoporos Rep"},{"key":"e_1_3_3_31_2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/BOR.0b013e328356d2f5","article-title":"FRAX updates 2012","volume":"24","author":"McCloskey E","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"e_1_3_3_32_2","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1007\/s00198-011-1713-z","article-title":"Interpretation and use of FRAX in clinical practice","volume":"22","author":"Kanis JA","year":"2011","journal-title":"Osteoporos Int"},{"key":"e_1_3_3_33_2","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.clinbiochem.2012.05.001","article-title":"Fracture risk assessment","volume":"45","author":"McCloskey E","year":"2012","journal-title":"Clin Biochem"},{"issue":"4","key":"e_1_3_3_34_2","first-page":"293","article-title":"2001 Medical Guidelines for Clinical Practice for the Prevention and Management of Postmenopausal Osteoporosis","volume":"7","author":"American Association of Clinical Endocrinologists","year":"2001","journal-title":"Endocr Pract"},{"key":"e_1_3_3_35_2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0002-9343(97)00019-3","article-title":"The prevention of early postmenopausal bone loss by cyclic etidronate therapy: a 2 years, double blind, placebo-controlled study","volume":"103","author":"Herd RJM","year":"1997","journal-title":"Am J Med"},{"issue":"14","key":"e_1_3_3_36_2","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial","volume":"282","author":"Harris ST","year":"1999","journal-title":"JAMA"},{"issue":"5","key":"e_1_3_3_37_2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women","volume":"344","author":"McClung MR","year":"2001","journal-title":"N Engl J Med"},{"key":"e_1_3_3_38_2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM199802193380801","article-title":"Prevention of bone loss with alendronate in postmenopausal women under 60 years of age","volume":"338","author":"Hosking D","year":"1998","journal-title":"N Engl J Med"},{"key":"e_1_3_3_39_2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.7326\/0003-4819-128-4-199802150-00001","article-title":"Alendronate prevents postmenopausal bone loss in women without osteoporosis. A double blind, randomised, controlled trial","volume":"128","author":"McClung MR","year":"1998","journal-title":"Ann Intern Med"},{"key":"e_1_3_3_40_2","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. Results from the fracture intervention trial","volume":"280","author":"Cumming SR","year":"1998","journal-title":"JAMA"},{"issue":"5","key":"e_1_3_3_41_2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/PL00004171","article-title":"Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax International Trial Study Group","volume":"9","author":"Pols HA","year":"1999","journal-title":"Osteoporos Int"},{"key":"e_1_3_3_42_2","first-page":"462","article-title":"The use of bisphosphonates in the treatment of osteoporosis","volume":"17","author":"Delmas PD","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"e_1_3_3_43_2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2036.2005.02378.x","article-title":"Upper gastrointestinal tolerability of once weekly alendronate 70 mg with concomitant non-steroidal anti-inflammatory drug use","volume":"21","author":"Cryer B","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"e_1_3_3_44_2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.maturitas.2003.12.012","article-title":"Patients with osteoporosis prefer once weekly to once daily dosing with alendronate","volume":"48","author":"Kendler D","year":"2004","journal-title":"Maturitas"},{"issue":"1","key":"e_1_3_3_45_2","first-page":"S276","article-title":"Treatment of osteoporosis with intravenous pamidronate: a retrospective analysis","volume":"14","author":"Calderari F","year":"1999","journal-title":"J Bone Miner Res"},{"issue":"1","key":"e_1_3_3_46_2","first-page":"S405","article-title":"Intermittent, intravenous pamidronate therapy: highly effective treatment for postmenopausal osteoporosis","volume":"16","author":"Wimalawansa SJ","year":"2001","journal-title":"J Bone Miner Res"},{"issue":"9","key":"e_1_3_3_47_2","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa011807","article-title":"Intravenous zoledronic acid in postmenopausal women with low bone mineral density","volume":"346","author":"Reid IR","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"e_1_3_3_48_2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1210\/jc.2012-2868","article-title":"Reduction in the risk of clinical fractures after a single dose of zoledronic acid 5 mg","volume":"98","author":"Reid IR","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_3_49_2","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors","volume":"23","author":"Bamias K","year":"2005","journal-title":"J Clin Oncol"},{"key":"e_1_3_3_50_2","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1359\/jbmr.081247","article-title":"Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study","volume":"24","author":"Abrahamsen B","year":"2009","journal-title":"J Bone Miner Res"},{"key":"e_1_3_3_51_2","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/jbmr.1893","article-title":"Bisphosphonates and risk of subtrochanteric, femoral shaft and atypical femur fracture: A systematic review and meta-analysis","volume":"28","author":"Gedmintas L","year":"2013","journal-title":"J Bone Miner Res"},{"key":"e_1_3_3_52_2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1185\/03007995.2012.663750","article-title":"Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation","volume":"28","author":"Cooper C","year":"2012","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"e_1_3_3_53_2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw JE","year":"2002","journal-title":"JAMA"},{"key":"e_1_3_3_54_2","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3 years randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (More) Investigators","volume":"282","author":"Ettinger B","year":"1999","journal-title":"JAMA"},{"issue":"10","key":"e_1_3_3_55_2","first-page":"S1","article-title":"Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada","volume":"167","author":"Brown JP","year":"2002","journal-title":"CMAJ"},{"key":"e_1_3_3_56_2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1701-2163(15)30489-8","article-title":"Osteoporosis in menopause","volume":"36","author":"Khan A","year":"2014","journal-title":"J Obstet Gynaecol Can"},{"issue":"229","key":"e_1_3_3_57_2","first-page":"F418","article-title":"The effects of raloxifene on incident vertebral fractures in postmenopausal women with osteoporosis: 4-year results from the MORE trial","volume":"15","author":"Eastell R","year":"2000","journal-title":"J Bone Miner Res"},{"key":"e_1_3_3_58_2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1006478317173","article-title":"Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial","volume":"65","author":"Cauley J","year":"2001","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"e_1_3_3_59_2","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/jama.287.7.847","article-title":"Raloxifene and Cardivascular events in osteoporotic postmenopausal women: four years results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial","volume":"287","author":"Barrett-Connor E","year":"2002","journal-title":"JAMA"},{"issue":"2","key":"e_1_3_3_60_2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women","volume":"355","author":"Barrett-Connor E","year":"2006","journal-title":"N Engl J Med"},{"key":"e_1_3_3_61_2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/bmj.305.6853.556","article-title":"Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose response study","volume":"305","author":"Overgaard K","year":"1992","journal-title":"BMJ"},{"key":"e_1_3_3_62_2","unstructured":"FDA Panel Says to Stop Salmon Calcitonin Downloaded March 23 2014. http:\/\/www.med-scape.com\/viewarticle\/780323."},{"key":"e_1_3_3_63_2","first-page":"3069","article-title":"Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects of bone mineral density and bone markers","volume":"85","author":"Kurland ES","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_3_64_2","first-page":"S 162","article-title":"Recombinant human parathyroid hormone (1\u201334) therapy reduces the incidence of moderate-severe vertebral fractures in men with low bone density","volume":"16","author":"Orwoll E","year":"2001","journal-title":"J Bone Miner Res"},{"key":"e_1_3_3_65_2","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effects of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer RM","year":"2001","journal-title":"N Engl J Med"},{"key":"e_1_3_3_66_2","first-page":"620","article-title":"A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis","volume":"82","author":"Hodsman AB","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_3_67_2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s001980050151","article-title":"Effect of an intermittent weekly dose of human parathyroid hormone (1\u201334) on osteoporosis: a randomized double-masked prospective study using three dose levels","volume":"9","author":"Fujita T","year":"1999","journal-title":"Osteoporos Int"},{"key":"e_1_3_3_68_2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis","volume":"350","author":"Meunier PJ","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"e_1_3_3_69_2","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1210\/jc.2004-1774","article-title":"Strontium ranelate reduces the risk of non-vertebral fracture in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study","volume":"90","author":"Reginster JY","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_3_70_2","unstructured":"Oral communication the 6th European congress on clinical and economic aspects of osteoporosis and osteoarthritis (ECCEO 6) Vienna Austria March 2006 Oral communication the 6th European congress on clinical and economic aspects of osteoporosis and osteoarthritis (ECCEO 6) JY Reginster Strontium ranelate: an anti-osteoporotic treatment demonstrated vertebral and non-vertebral anti-fracture efficacy over 5 years in postmenopausal osteoporotic women"},{"issue":"2","key":"e_1_3_3_71_2","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1210\/jc.2012-3048","article-title":"Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men","volume":"98","author":"Kaufman JM","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"e_1_3_3_72_2","first-page":"s114","article-title":"Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men","volume":"22","author":"Kaufman JM","year":"2011","journal-title":"Osteoporos Int"},{"key":"e_1_3_3_74_2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin (OPG) ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey DL","year":"1998","journal-title":"Cell"},{"key":"e_1_3_3_75_2","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1073\/pnas.96.7.3540","article-title":"Tumour necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand","volume":"96","author":"Hsu H","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_3_76_2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/74999","article-title":"Osteoprotegerin blocks bone cancer induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord","volume":"6","author":"Honore P","year":"2000","journal-title":"Nat Med"},{"key":"e_1_3_3_77_2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1084\/jem.192.4.463","article-title":"Osteopprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevenst vascular calcification by blocking a process resembling osteoclastogenesis","volume":"192","author":"Min H","year":"2000","journal-title":"J Exp Med"},{"key":"e_1_3_3_78_2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet WS","year":"1997","journal-title":"Cell"},{"issue":"9","key":"e_1_3_3_79_2","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1210\/jc.2012-1569","article-title":"A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density","volume":"97","author":"Orwoll E","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_3_80_2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jbspin.2003.09.004","article-title":"Nonpharmacologic prevention of osteoporotic fractures","volume":"70","author":"Deprez X","year":"2003","journal-title":"Joint Bone Spine"},{"issue":"21","key":"e_1_3_3_81_2","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM200011233432101","article-title":"Prevention of hip fracture in elderly people with use of a hip protector","volume":"343","author":"Kannus P","year":"2000","journal-title":"N Engl J Med"},{"key":"e_1_3_3_82_2","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S8756-3282(02)00739-1","article-title":"Stronger back muscles reduce the incidence of vertebral fractures: a prospective 10 year follow-up of postmenopausal women","volume":"30","author":"Sinaki M","year":"2002","journal-title":"Bone"},{"key":"e_1_3_3_83_2","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/j.1532-5415.1999.tb01556.x","article-title":"Home visit by occupational therapist for assessment and modification of environmental hazards: a randomized controlled trial of falls prevention","volume":"47","author":"Cumming R","year":"1999","journal-title":"J Am Geriatric Soc"},{"key":"e_1_3_3_84_2","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1532-5415.1999.tb03843.x","article-title":"Psychotropic medication withdrawal and a home based exercise program to prevent falls: result of a randomized controlled trial","volume":"47","author":"Campbell AJ","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"e_1_3_3_85_2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/1756-185x.12037","article-title":"The Malaysian clinical guidance on the management of postmenopausal osteoporosis, 2012: a summary","volume":"16","author":"Yeap SS","year":"2013","journal-title":"Int J Rheum Dis"},{"key":"e_1_3_3_86_2","article-title":"Bone mineral density across a range of physical activity volumes: NHANES 2007\u20132010","author":"Whitfield GP","year":"2014","journal-title":"Med Sci Sports Exerc"},{"key":"e_1_3_3_87_2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1471-2431-12-92","article-title":"Effect of physical activity and sun exposure on vitamin D status of Saudi children and adolescents","volume":"12","author":"Al-Othman A","year":"2012","journal-title":"BMC Pediatr"},{"key":"e_1_3_3_88_2","article-title":"Physical activity-associated bone loading during adolescence and young adulthood is positively associated with adult bone mineral density in men","author":"Strope MA","year":"2014","journal-title":"Am J Mens Health"}],"container-title":["Annals of Saudi Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.annsaudimed.net\/index.php\/vol35\/vol35iss1\/781.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T10:52:05Z","timestamp":1579171925000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.annsaudimed.net\/doi\/10.5144\/0256-4947.2015.1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["10.5144\/0256-4947.2015.1"],"URL":"https:\/\/doi.org\/10.5144\/0256-4947.2015.1","relation":{},"ISSN":["0256-4947","0975-4466"],"issn-type":[{"value":"0256-4947","type":"print"},{"value":"0975-4466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}